Related Experiment Video
Updated: Jul 9, 2025
Stretching Micropatterned Cells on a PDMS Membrane
Published on: January 22, 2014
A Flexible PDMS-Based Optical Biosensor for Stretch Monitoring in Cardiac Tissue Samples
Andrea Sannino1, Antonio Velarte2, Aránzazu Otín1
1Group of Power Electronics and Microelectronics, Aragon Institute for Engineering Research, University of Zaragoza, 50018 Zaragoza, Spain.
Abstract:
Cardiotoxicity, characterized by adverse impacts on normal heart function due to drug exposure, is a significant concern due to the potentially serious side effects associated with various pharmaceuticals. It is essential to detect the cardiotoxicity of a drug as early as possible in the testing phase of a medical composite. Therefore, there is a pressing need for more reliable in vitro models that accurately mimic the in vivo conditions of cardiac biopsies. In a functional beating heart, cardiac muscle cells are under the effect of static and cyclic stretches. It has been demonstrated that cultured cardiac biopsies can benefit from external mechanical loads that resemble the in vivo condition, increasing the probability of cardiotoxicity detection in the early testing stages. In this work, a biosensor is designed and fabricated to allow for stretch monitoring in biopsies and tissue cultures using an innovative sensing mechanism. The detection setup is based on a biocompatible, thin, flexible membrane-where the samples are attached-which is used as an optical waveguide to detect pressure-caused shape changes and stretches. Various prototypes have been fabricated with a cost-effective process, and different measurements have been carried out to experimentally validate the proposed measurement technique. From these evaluations, stretches of up to 1.5% have been measured, but the performed simulations point towards the possibility of expanding the considered technique up to 10-30% stretches.
Insights
This study introduces an innovative biosensor for monitoring stretch in cardiac biopsies, crucial for early drug-induced cardiotoxicity detection. The device uses a flexible optical waveguide membrane to measure mechanical loads, improving in vitro model accuracy.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Materials Science
Background:
- Drug-induced cardiotoxicity poses significant risks, necessitating early detection during pharmaceutical development.
- Current in vitro models often fail to replicate the mechanical stresses (static and cyclic stretches) experienced by cardiac muscle cells in vivo.
- Accurate assessment of mechanical loads on cardiac tissues is vital for reliable cardiotoxicity screening.
Purpose of the Study:
- To design and fabricate a novel biosensor for monitoring stretch in cardiac biopsies and tissue cultures.
- To develop a cost-effective and reliable method for assessing mechanical stimuli in in vitro cardiac models.
- To enhance the accuracy of early-stage cardiotoxicity detection by mimicking in vivo mechanical conditions.
Main Methods:
- Fabrication of a biosensor utilizing a biocompatible, thin, flexible membrane as an optical waveguide.
- Integration of the sensing membrane for sample attachment, enabling detection of pressure-induced shape changes and stretches.
- Experimental validation of the biosensor's measurement technique through various prototype tests and simulations.
Main Results:
- Successful fabrication of cost-effective biosensor prototypes.
- Experimental validation demonstrating the measurement of stretches up to 1.5%.
- Simulations indicating the potential for the technique to measure stretches ranging from 10% to 30%.
Conclusions:
- The developed biosensor offers a promising tool for monitoring mechanical stretch in cardiac tissue models.
- This technology can significantly improve the reliability of in vitro cardiotoxicity testing by simulating in vivo conditions.
- The biosensor's capability to measure physiological stretch levels paves the way for more accurate pharmaceutical safety assessments.
